Marketing - Press Releases

Date	Title	Company
06-Apr-2020	Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme	Ergomed plc
06-Apr-2020	Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy	Izana Bioscience
06-Apr-2020	Global Rat Model Market Research Report \| Charles River laboratories, genOway S.A., Covance, Inc., Harlan Laboratories, Inc., Janvier Labs, SAGE Labs, Transposagen Bioph	Ricerca Alfa
06-Apr-2020	Global Infusion Pumps and Accessories Market Research Report \| Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co., Smiths Medical, Johnson & Johnson, Becton, Dickinson and Company, ICU Medical, Inc., CME Medical UK Limited, Moog, Inc., and Terumo Corporation	Ricerca Alfa
03-Apr-2020	Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline	Servier
03-Apr-2020	Availability of Preparatory Documents for the Combined General Meeting of May 27, 2020	Transgene
03-Apr-2020	Coeliac UK launches appeal to keep support going for thousands with autoimmune disease	National charity Coeliac UK
03-Apr-2020	The Alliance for Regenerative Medicine to Host FDA Representatives for Webinar on Clinical Trial Guidance During COVID-19 on April 10, 2020	The Alliance for Regenerative Medicine
03-Apr-2020	Availability of the Pre-quarterly Results Communication	Sanofi
03-Apr-2020	Mistura Informatics Donates Medicines Information Software to Tackle COVID-19	Mistura Informatics
02-Apr-2020	FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENCE APPLICATION FOR RYONCIL™ AND AGREES TO PRIORITY REVIEW	Mesoblast Limited
02-Apr-2020	Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™	Emergent BioSolutions
02-Apr-2020	INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia	INOVIO Pharmaceuticals, Inc
02-Apr-2020	REGENERON ANNOUNCES AMERICAN COLLEGE OF CARDIOLOGY PRESENTATION OF POSITIVE PHASE 3 EVINACUMAB RESULTS IN PATIENTS WITH SEVERE INHERITED FORM OF HIGH CHOLESTEROL	Regeneron Pharmaceuticals, Inc.
02-Apr-2020	Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines	Eli Lilly and Company
02-Apr-2020	UTILITY Therapeutics Announces Leadership Changes	UTILITY Therapeutics
02-Apr-2020	BCMPA WELCOMES NEW RULES GOVERNING THE MANUFACTURE OF HAND SANITISERS IN THE UK	The British Contract Manufacturers and Packers Association (BCMPA)
02-Apr-2020	MANN+HUMMEL implements global activities and transfers its filter media competence to new markets	MANN+HUMMEL
02-Apr-2020	Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites	Panthera Biopartners
02-Apr-2020	Due to COVID-19, Pain Therapeutics Conference will be accessed remotely	SMi Group